EX-2.1
from 8-K
141 pages
Agreement and Plan of Merger by and Among: Sensei Biotherapeutics, Inc., a Delaware Corporation; Sapphire First Merger Sub, Inc., a Delaware Corporation; Sapphire Second Merger Sub, LLC, a Delaware Limited Liability Company; Faeth Holdings Therapeutics, Inc., a Delaware Corporation; and Faeth Therapeutics, LLC, a Delaware Limited Liability Company Dated as of February 17, 2026
12/34/56
